94 related articles for article (PubMed ID: 10416822)
1. In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.
Fredriksson A; Johnström P; Thorell JO; von Heijne G; Hassan M; Eksborg S; Kogner P; Borgström P; Ingvar M; Stone-Elander S
Life Sci; 1999; 65(2):165-74. PubMed ID: 10416822
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats.
Samén E; Arnberg F; Lu L; Olofsson MH; Tegnebratt T; Thorell JO; Holmin S; Stone-Elander S
J Nucl Med; 2013 Oct; 54(10):1804-11. PubMed ID: 24003078
[TBL] [Abstract][Full Text] [Related]
3. [Molecular imaging of epidermal growth factor receptor in glioma-bearing rats].
Wang H; Yu JM; Song XR; Yang GR; Mu DB; Zhao SQ; Wang XW; Wei L; Liu YL; Song B; Fu Z; Teng XP
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):343-6. PubMed ID: 18953832
[TBL] [Abstract][Full Text] [Related]
4. Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression.
Wang H; Yu J; Yang G; Song X; Sun X; Zhao S; Mu D
Cancer Sci; 2007 Sep; 98(9):1413-6. PubMed ID: 17627611
[TBL] [Abstract][Full Text] [Related]
5. Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.
Dai D; Li XF; Wang J; Liu JJ; Zhu YJ; Zhang Y; Wang Q; Xu WG
Int J Cancer; 2016 Feb; 138(4):1003-12. PubMed ID: 26334931
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice.
Kunkel MW; Hook KE; Howard CT; Przybranowski S; Roberts BJ; Elliott WL; Leopold WR
Invest New Drugs; 1996; 13(4):295-302. PubMed ID: 8824347
[TBL] [Abstract][Full Text] [Related]
7. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.
Liu N; Li M; Li X; Meng X; Yang G; Zhao S; Yang Y; Ma L; Fu Z; Yu J
J Nucl Med; 2009 Feb; 50(2):303-8. PubMed ID: 19164239
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of the epidermal growth factor receptor ligand 11C-PD153035.
Wang H; Yu JM; Yang GR; Song XR; Sun XR; Zhao SQ; Wang XW; Zhao W
Chin Med J (Engl); 2007 Jun; 120(11):960-4. PubMed ID: 17624262
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [11C]RPR-72840A and its evaluation as a radioligand for the serotonin reuptake site in positron emission tomography.
Roeda D; Tavitian B; Coulon C; David F; Dollé F; Fuseau C; Jobert A; Crouzel C
Bioorg Med Chem; 1997 Feb; 5(2):397-403. PubMed ID: 9061204
[TBL] [Abstract][Full Text] [Related]
10. Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivo.
Wu F; Orlefors H; Bergström M; Antoni G; Omura H; Eriksson B; Watanabe Y; Långström B
Anticancer Res; 2000; 20(1A):251-6. PubMed ID: 10769663
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas.
Sun J; Cai L; Zhang K; Zhang A; Pu P; Yang W; Gao S
Clin Nucl Med; 2014 Jan; 39(1):e20-6. PubMed ID: 24335566
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride.
Ben-David I; Rozen Y; Ortu G; Mishani E
Appl Radiat Isot; 2003 Feb; 58(2):209-17. PubMed ID: 12573320
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro.
Samén E; Thorell JO; Fredriksson A; Stone-Elander S
Nucl Med Biol; 2006 Nov; 33(8):1005-11. PubMed ID: 17127174
[TBL] [Abstract][Full Text] [Related]
14. Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.
McKillop D; Hutchison M; Partridge EA; Bushby N; Cooper CM; Clarkson-Jones JA; Herron W; Swaisland HC
Xenobiotica; 2004 Oct; 34(10):917-34. PubMed ID: 15764411
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.
Memon AA; Jakobsen S; Dagnaes-Hansen F; Sorensen BS; Keiding S; Nexo E
Cancer Res; 2009 Feb; 69(3):873-8. PubMed ID: 19155297
[TBL] [Abstract][Full Text] [Related]
16. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study.
Meng X; Loo BW; Ma L; Murphy JD; Sun X; Yu J
J Nucl Med; 2011 Oct; 52(10):1573-9. PubMed ID: 21903741
[TBL] [Abstract][Full Text] [Related]
18. Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.
Ortu G; Ben-David I; Rozen Y; Freedman NM; Chisin R; Levitzki A; Mishani E
Int J Cancer; 2002 Oct; 101(4):360-70. PubMed ID: 12209961
[TBL] [Abstract][Full Text] [Related]
19. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography.
Roivainen A; Forsback S; Grönroos T; Lehikoinen P; Kähkönen M; Sutinen E; Minn H
Eur J Nucl Med; 2000 Jan; 27(1):25-32. PubMed ID: 10654143
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
Fozing T; Scheuer C; Samnick S
Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
